DB05163ExperimentalSmall molecule
PV903 is a self administered vaginally delivered recombinant protein for the treatment of recurrent miscarriage, resulting from an intolerant immune response to the developing foetus.
- Primary indication
- Investigated for use/treatment in infertility.Curator reviewed
- Code names
- PV903
Which companies are running trials of PV903, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account